EFFICACY AND SAFETY OF TELBIVUDINE USE IN HIGHLY VIREMIC MOTHERS WITH HBEAG plus CHRONIC HEPATITIS B (CHB) IN CLINICAL PRACTICE

被引：0
|
作者：
Han, G. [1 ]
Jiang, H. [1 ]
Zhao, W. [2 ]
Ge, C. [3 ]
Xu, C. [3 ]
机构：
[1] Southeast Univ, Dept Gynecol & Obstet, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China
[2] Southeast Univ, Dept Infect Dis, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China
[3] Southeast Univ, Dept Gynecol & Obstet, Sch Med, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
512
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF LAMIVUDINE USE IN HIGHLY VIREMIC MOTHERS WITH HBEAG plus CHRONIC HEPATITIS B (CHB) IN CLINICAL PRACTICE
    Pan, Calvin
    Han, Guo Rong
    Jiang, Hong Xiu
    Ge, Chun Yan
    Xu, Chuan Lu
    Zhao, Wei
    HEPATOLOGY, 2011, 54 : 881A - 882A
  • [2] EFFECTS OF HEPATITIS B IMMUNE GLOBULIN (HBIG) INJECTIONS ON PREVENTING VERTICAL TRANSMISSION (VT) IN HIGHLY VIREMIC MOTHERS WITH HBEAG plus CHRONIC HEPATITIS B (CHB)
    Zou, Huaibin
    Chen, Yu
    Duan, Zhongping
    Zhang, Hua
    Pan, Calvin
    HEPATOLOGY, 2011, 54 : 889A - 890A
  • [3] Long-term safety and efficacy of infants born to telbivudine treated highly viremic mothers with HBeAg positive chronic hepatitis B (CHB) during 2nd or 3rd trimester
    Han, Guo Rong
    Jiang, Hong Xiu
    Wang, Cui-min
    Ding, Yi
    Yue, Xin
    Wang, Gen-ju
    Yang, Yong-Feng
    HEPATOLOGY, 2013, 58 : 654A - 654A
  • [4] COMPARISON OF TELBIVUDINE USE IN THE 2ND AND 3RD TRIMESTER OF PREGNANCY IN PREVENTING VERTICAL TRANSMISSION IN HIGHLY VIREMIC CHRONIC HEPATITIS B (CHB) MOTHERS
    Han, G.
    Zhao, W.
    Ge, C.
    Xu, C.
    Jiang, H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S202 - S203
  • [5] CLINICAL FEATURES AND OUTCOMES OF HBEAG plus CHRONIC HEPATITIS B (CHB) IN PREGNANT WOMEN
    Pan, Calvin
    Han, Guo Rong
    Cao, Min Kai
    Zhao, Wei
    Jiang, Hong Xiu
    HEPATOLOGY, 2010, 52 (04) : 1006A - 1006A
  • [6] Efficacy and Safety of Telbivudine Compared to Entecavir Among HBeAg plus Chronic Hepatitis B Patients: a Meta-Analysis Study
    Liang, Jian
    Jiang, Man Jun
    Deng, Xin
    Zhou, Xiao Xiao
    HEPATITIS MONTHLY, 2013, 13 (06)
  • [7] EFFICACY AND SAFETY OUTCOMES AFTER 4 YEARS OF TELBIVUDINE TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
    Wang, Yuming
    Thongsawat, Satawat
    Gane, Edward J.
    Liaw, Yun-Fan
    Jia, Jidong
    Manns, Michael P.
    Hou, Jinlin
    Chan, Henry Lik-Yuen
    Papatheodoridis, George V.
    Wan, Mobin
    Niu Junqi
    Bao, Weibin
    Lopez, Patricia M.
    Naoumov, Nikolai V.
    HEPATOLOGY, 2009, 50 (04) : 533A - 533A
  • [8] EFFICACY AND SAFETY OF TELBIVUDINE IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS WITH HIGH BASELINE ALT LEVELS
    Lv Guocai
    Ma Wenjiang
    Ying Linjuan
    Jin Xi
    Zheng Lin
    Li Lan-juan
    Yang Yida
    HEPATOLOGY, 2010, 52 (04) : 552A - 553A
  • [9] Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B
    Tianyu He
    Yuqing Bai
    Haodong Cai
    Xiaojuan Ou
    Min Liu
    Wei Yi
    Jidong Jia
    Hepatology International, 2018, 12 : 118 - 125
  • [10] Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B
    He, Tianyu
    Bai, Yuqing
    Cai, Haodong
    Ou, Xiaojuan
    Liu, Min
    Yi, Wei
    Jia, Jidong
    HEPATOLOGY INTERNATIONAL, 2018, 12 (02) : 118 - 125
12345